Terry J. Bellnier

Terry Bellnier

Terry J. Bellnier


Professional Summary:

Research interests focused to the areas of pharmacoeconomics, drug efficacy, safety, and side effect management of psychotropics.

Education and Training:

  • Advanced Clinical Research Associate, DIA, DIA (1997)
  • Master of Public Administration, Public Administration/Masters, SUNY Brockport (1990)
  • BS, Pharmacy, University of Georgia, College of Pharmacy (1977)

Employment:

  • Chairman, Geriatric Pharmacotherapy Institute, Inc. (2001-present)
  • Director, Psychiatric Pharmacy Practice Program, Pharmacy Practice, The State University of NY at Buffalo (2000-present)
  • Assistant Clinical Professor, Pharmacy Practice, The State University of NY at Buffalo (1997-present)
  • Director of Pharmacy, Rochester Psychiatric Center (1987–2002)
  • Psychopharmacology Educator, Rochester Psychiatric Center (1984–2002)
  • Director of Education, Geriatric Pharmacotherapy Institute, Inc. (1994–2001)
  • Adjunct Faculty, SUNY Brockport/Public Administration (1993–1994)
  • Clinical Pharmacist, Rochester Psychiatric Center (1984–1987)
  • Community Pharmacy Manager (1978–1981)

Awards and Honors:

  • Merck Recipient- Outstanding Contribution to Pharmacy Profession (1990)



Professional Memberships:

  • American Society of Consultant Pharmacists - Fellow
  • American College of Clinical Pharmacy
  • Drug Information Association
  • International Society of Pharmacoeconomics and Outcomes Research

Presentations:

  • "Therapeutic Interchange of Divalproex DR with Divalproex ER through the continuum of care," ASCP Annual Meeting (2006)
  • "Advancements in Treatment of MDD and Neuropathic Pain" Idaho State University (2006)
  • "The Prevalence of Thyroid Dysfunction in Schizophrenia" APA Annual Meeting (2006)
  • "Safety Profile Associated with the Concomitant Use of Lorazepam injection with Olanzapine, Ziprasidone or Haloperidol Injection" CPNP Annual Meeting (2006)
  • "Nutrition and Exercise in the Severe and Persistently Mentally Ill: An Effect on Metabolic Syndrome Risk Factors" APA Annual Meeting (2005)
  • "Nutrition and Exercise in the Severe and Persistently Mentally Ill: An Effect on Metabolic Syndrome Risk Factors" APA Annual Meeting (2005)
  • "The Change in Prevalence Over Five Years of Metabolic Syndrome Risk in Severe and Persistently Mentally Ill Patients Receiving Atypical Antipsychotics" APA Annual Meeting (2005)
  • "The Pharmacology of Neuropathic Pain" Dent Neurologic Institute (2004)
  • "Advancements in the Treatment of Major Depressive Disorder" ViaHealth (2004)
  • "The cost to treat severe agitation" Annual Meeting of The College of Psychiatric and Neurologic Pharmacists (CPNP) (2004)
  • "Diabetes and Atypical Antipsychotics" University at Pittsburgh (2004)
  • "Evaluate the costs of treatment of severe agitation in a state psychiatric hospital" American Society of Healthcare Pharmacists Mid-Year Clinical Meeting, National Meeting (2003)
  • "Long-term Effectiveness and Adherence with Atypical Antipsychotics" Community Healthlink (2003)
  • "Metabolic Issues in Severe Mental Illness" Canadian Metabolic Working Group, Lilly-Canada (2003)
  • "The Evolution of Antipsychotics" Pharmacist’s Association of Western New York (2003)
  • "The Treatment of Acute Agitation in the Geriatric Patient" Strong Health Geriatric Care Team (2003)
  • "Effectiveness of fluoxetine weekly compared to fluoxetine daily in general practice identify the importance of improving medication compliance by reducing doses administered." APA Annual Meeting (2003)
  • "Efficacy and Safety of Olanzapine in Risperidone Resistant Treatment Refractory Schizophrenia" CPNP Annual Meeting (2003)
  • "Evaluate the Effectiveness of Fluoxetine 90mg Administered Every Week and Every 2 weeks in Nursing Home Residents" ISPOR (2003)
  • "Prevalence of Metabolic Issues in Schizophrenic and Bipolar Patients prior to Widespread use of Antipsychotics" APA Annual Meeting (2003)
  • "The Pharmacotherapy of Addiction," Maine Behavioral Health Network (2003)
  • "The Prevalence of Metabolic Disturbances in State Hospital Patients Prior to the use of Antipsychotics and After the Widespread Use of Atypical Antipsychotics" CPNP Annual Meeting (2003)
  • "The Role of Psychotrophics in Mood Disorders - Grand rounds" Newark Wayne Hospital (2003)
  • "The Evolution of the Pharmacotherapy of ADHD" Regional APA Meeting (2002)
  • "Bipolar Disorder: Update" (2002)
  • "Comorbid Substance Abuse in Severe Mental Illness" (2002)
  • "Cost-Effectiveness of Fluoxetine Weekly in a Long-Term Care Setting" ISPOR, European Congress (2002)
  • "Metabolic Issues in Antipsychotic Pharmacotherapy" (2002)
  • "Neurobiology of Weight Control" Eastern Maine Medical Center (2002)
  • "Metabolic Issues in Severe Mental Illness" Schizophrenia Advisory Board, Meeting - Lilly (2002)
  • "Optimal Dosing of Olanzapine" APA Annual Meeting (2002)
  • "Update on the Treatment of Agitated Dementia" AMDA NYS meeting (2002)
  • "Anticonvulsants in the Treatment of Schizophrenia" (2002)
  • "Evaluation of a Nutrition/Exercise Psychoeducation Program for the Severe and Persistently Mentally Ill" ASHP Midyear Meeting (2001)
  • "Treating the Acutely Agitated Patient" ASHP Midyear Clinical Meeting (2001)
  • "Contemporary Issues in Antipsychotic Pharmacotherapy" VA Hospital - Maine Center (2001)
  • "Comparative Pharmacology of Atypical Antipsychotics" ACCP Annual Meeting (2001)
  • "Contemporary Issues in Antipsychotic Pharmacotherapy" (2001)
  • "Comparative Efficacy and Safety of Atypical Antipsychotics" (2001)
  • "New Treatment Approaches to Managing Depression" (2001)
  • "Pharmacology of Agitation in the Elderly" (2001)
  • "Comparative Weight Change with Atypical Antipsychotic Treatment" APA Annual Meeting (2001)
  • "Prevalence of Cardiovascular Disease Comorbidities and Risk Factors in Severe and Persistently Mentally Ill Patients" APA Annual Meeting (2001)
  • "Treatment Costs of Cardiovascular Disease Comorbidities in Severe and Persistently Mentally Ill" ISPOR Annual Meeting (2001)
  • "Update of Geriatric Psychopharmacology" (2001)
  • "The Role of Norephinephrine and Depression" (2001)
  • "Efficacy and Side Effects of Atypical Antipsychotics" (2001)
  • "Pharmacoeconomics of Depression" (2001)
  • "Advances in Treatment of Refractory Schizophrenia" (2001)
  • "Comparative Efficacy of Atypical Antipsychotics" (2001)
  • "Comorbidity and Cardiovascular Disease Risk Factors in Severe and Persistently Mentally Ill" NYS OMH Research Conference (2000)
  • "Safety and Side Effects in Perspective" (2000)
  • "Side Effects in Perspective" (2000)
  • "Weight Gain and Psychotropics" (2000)
  • "Cost-Effectiveness of Atypical Antipsychotics" ASCP Annual Meeting (2000)
  • "Evaluation of Usage of Medication for Management of Glaucoma in Nursing Home Patients" ACCP Annual Meeting (2000)
  • "Pharmacoeconomics of Atypical Antipsychotics: update" (2000)
  • "Cost-Effectiveness of Atypical Antipsychotics in Chronic Schizophrenia" ISPOR Annual Meeting (2000)
  • "Mood Stabilizers in Psychiatry," (2000)
  • "Agitation in Dementia" (1999)
  • "Diabetes Update" (1999)
  • "Everything You Wanted to Know About Generics but were Afraid to Ask, APA Psychiatric Institute" (1999)
  • "An Evaluation of the Interchangeability of Generic Clozapine with Brand Name Clozapine" APA Annual Meeting (1999)
  • "Interchangeability of Generic Clozapine with Clozaril" (1999)
  • "Therapeutic Interchange of Divalproex and Valproic Acid" (1999)
  • "Cost-Effectiveness and Efficacy of Atypical Antipsychotics" PsychLink Video (1999)
  • "Evaluation of dose Equivalency of Atypical Antipsychotics to Haloperidol in the Management of Agitation in the Elderly" NYS OMH Research Conference (1998)
  • "Weight Gain in Risperidone Treated State Hospital Patients" NYS OMH Research Conference, (1998)
  • "Weight Gain in Risperidone Treated State Hospital Patients" NYS OMH Research Conference (1998)
  • "Evaluation of Dose Equivalency of Risperidone to Haloperidol in the Management of Agitation in the Elderly" ACCP Annual Meeting (1998)
  • "Evaluation of the Dose Equivalency of Olanzapine to Haloperidol in the Management of Agitation in the Elderly" ASCP Annual Meeting (1998)
  • "Evidenced Based Prescribing: The Role of Atypical Antipsychotics" RIPA (1998)
  • "Geriatric Pharmacotherapy Update: Osteoporosis" Oswego Mental Health (1998)
  • "An Evaluation of Olanzapine in Risperidone Refractory Schizophrenic/Schizoaffective Patients" APA Annual Meeting, (1998)
  • "Evaluation of a Therapeutic Interchange Program" APA Annual Meeting (1998)
  • "Pharmacoeconomics of Atypical Antipsychotic" (1998)
  • "When Atypicals Become Typical" Oswego Mental Health (1998)
  • "Psychosis in the Elderly" Unity Heath Systems (1998)
  • "A State Hospital Experience with Olanzapine" NYS OMH Research Conference (1997)
  • "Diabetes in the Elderly" Unity Health Systems (1997)
  • "Therapeutic Interchange of Divalproex Sodium with Valproic Acid" NYS OMH Research Conference, (1997)
  • "Clinical Efficacy of Sertraline Three Times a Week as Compared with Once a Day Regimen" ACCP Annual Meeting (1997)
  • "mpact of a Team Approach on Reducing Costs of Antidepressant Medication in a Community Nursing Home" ASCP Annual Meeting (1997)
  • "Pharmacist Management of Anticoagulation Therapies in a Community Nursing Home" ACCP Annual Meeting (1997)
  • "Usage Patterns of Antidepressant Medications in an Academic Nursing Home" ASCP Annual Meeting (1997)
  • "Peptic Disorders in the Elderly" Unity Health Systems (1997)
  • "Introduction to Geriatrics and Geriatric Pharmacotherapy of Psychiatry and Neurology" Symposium on Geriatric Pharmacotherapy, Monroe Community Hospital (1997)
  • "A Pharmaceutical Care Outcome Pilot Study in a Psychiatric Rehabilitation Program" NYS OMH Research Conference (1996)
  • "Introduction to Geriatric Pharmacotherapy" Symposium on Geriatric Pharmacotherapy - Monroe Community Hospital (1996)
  • "A State Hospital Experience with Risperidone" NYS OMH Research Conference (1994)
  • "Adjunctive Captopril in the Treatment of Polydipsia" NYS OMH Research Conference (1994)
  • "Granulocyte Colony Stimulating Factor as a Treatment for Clozapine Induced Agranulocytosis" NYS OMH Research Conference (1993)
  • "An Automated Medication Administration Record and Physician Orders" NYS OMH Nursing Conference (1993)
  • "Computer-Assisted Program for Reducing Chemical Restraints on a Psycho-Geriatric Unit" NYS OMH Nursing Conference (1993)
  • "Psychopharmacology in the Elderly" Genesee Co. Mental Health Department (1993)
  • "A two year Study of Clozapine-Induced Weight Gain" NYS OMH Research Conference (1992)
  • "Clozapine-Over Two Years Experience" NYS Council of Hospital Pharmacists (1991)
  • "Advances in the Treatment of Schizophrenia" Westchester Society of Hospital Pharmacists (1991)
  • "Weight Gain in Clozapine Treated Schizophrenics" nternational Congress on Schizophrenia Research (1991)
  • "Clozapine-Two Years Experience" NYS OMH Research Conference (1990)
  • "Drug Usage Evaluation-two Years Experience" NYS OMH, Directors Conference (1989)
See all (91 more)

School News:

In the Media:


Clinical Specialties:

Clinical Offices:

Insurance Accepted:



Contact Information


Fax: (585) 594-3873
bellnier@buffalo.edu